development agreement
Dec 1 (Reuters) - Uni-bio Science Group Ltd 0690.HK :
* unit entered into a multiple drug co-development agreement
with Beijing Sun-Novo Pharmaceutical Research Co., Limited
* deal to extend group's current research and development
capabilities in small molecule drug development
* Project is targeted to start in 2017 and launch sales in
market around 2020-2021
Source text: (http://bit.ly/2gBHcEU)
Further company coverage: 0690.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsUni-Bio Science H1 revenue falls 12% on pricing changes
Brief: Uni-Bio Science Expects Net Profit Of Hk$30 Million For Six Months Ended June 2026
Brief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA